MARGO MARTINEZ: Open Payments
NPI 1124205406 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 22 payments from 11 companies in 2025. Trend: 2023 $429 · 2024 $301 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $341 |
| Lilly USA, LLC | 4 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $142 |
| Novo Nordisk Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| Lundbeck LLC | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Gilead Sciences, Inc. | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: APRETUDE, REXULTI, Kerendia, Ozempic, KISUNLA, CABENUVA, AIRSUPRA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
